HLA-C and colorectal carcinoma: Developing neoantigen prediction methods, such as TruNeo, which is based on several biological processes rather than only predicting peptide‐MHC binding affinity methods, using novel algorithms, and identifying neoantigens‐specific T cells in the preparation phase, can improve the effectiveness of the NRT immunotherapy in CRC.